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Starting with ethyl l-arninoanthraquinone-z-carboxy-
late, the synthesis of 3-arnino/3-alkyl-2,4-dioxo-I,2,3,4-
tetrahydropyrimidol[ 4,5-a]anthraquinones and some re-
lated compounds is described.
During the last years, special attention has been
focused on the synthesis and biological properties
of pyrimidin-4-ones and particularly on their 3-
amino derivatives, fused with different carbocyclic
or heterocyclic systems, such as benzene (quina-
zolinones), benzothiophene, pyrozoles, imidazole
and 1,2,3-triazole due to their potential pharma-
I . I' 1-10 Th dco ogrca Interest. ese compoun s are
generally obtained by the cyclisation of o-amino-
aryl hydrazine with orthoesters":". However, this
reaction may yield different products, namely 3-
aminopyrimidin-4-ones, the respective triazepi-
nones or also oxadiazoles, depending -on the
reagents, their molar proportion, the solvents and
other conditions. The most suitable conditions to
obtain each product, and the mechanisms, have
been studied in detail with the anthra-
nilichydrazides'". In continuation of our earlier
work on the synthesis and biol09ical properties offused systems of anthraquinone 1-18, we describe
herein the synthesis of 3-amino/3-alkyl-2,4-dioxo-
1, 2, 3,4-tetrahydropyrimido[ 4,5-a ]anthraquinones.
The compounds were obtained as illustrated in
Scheme 1. Boiling a solution of 1with ethyl/methyl
chloroformate in xylene gave 2a, b which were
cyclised to 3 with hydrazine hydrate. The IH NMR
spectra of3 showed a signal at 85.7 (s, 2H), which
was assigned to the 3-amino group. According to
h I· 138-10 3 . idazi 4 ht e rterature" -arnmopyn azm- -ones s ow
in the IH NMR spectra a signal at 8 5.0-6.0 (3, bs,
2H, 3-NH2), which disappears on addition of
Note
deuterium oxide. In the isomeric tria eR'nones t '¢
signals for the protons of the syste O-N
NH-CX-(X=N, 0) appear at values o~>, .02 as t 0
different signals (s, bs). On refluxinj ompou CI
2a-b with excess aliphatic amines, gave 4a .
Treatment of 1 with hydrazine ydrate g
compound 5. Further, reaction of with et )'II
orthoformate yielded compound 6 (80 Vol . IH N
spectra of 6 showed a signal at () 5 5 for the 3-
amino group. In view of the wi e range of
pharmacological properties reportedt 'r vari• 19-24 d I Iqumone structures an severa t er re a ecompounds, the various anthraquino e Herivati e
prepared now would be screene for th] ir
biological activity and the result would , e
published elsewhere.
Experimental Section
All melting points are
spectra were recorded on
spectrophotometer using potassiu bromi
IH NMR spectra in DMSO-d6 on a V r an Gem
300 MHz spectrophotometer (chemic I hifts in
ppm downfield from TMS as inter al standa
and mass spectra on Kartos MS 8 FA m ss
spectrometer at 70ev. Satisfactor C, H,
analysis were obtained.
Ethyl l-[(ethoxycarbonyl)amino a thraqu n
one-2-carboxylate 2a. Toa suspensi n f 1 (0.5 )~
g, 0.002 mole) in xylene (10 mL) e cess et ~I
chloroformate (3 mL) was added. e reactio
mixture was then refluxed for 7 hr. Tpe precipit t
obtained on cooling was filtered, was e with c I
ethanol and crystallised from ethan I.IIR (K r]:
3200 (NH), 1735, 1672 (C=O), 1640 CrN), 15 ,
'1509 (C=C).
Ethyl l-[(methoxycarbonyl)amin ]anthraq
none-2-carboxylate 2b. The above p ocedure a
repeated with a modification whe e n, met)ll
chloroformate was used instea of et I
chloroformate. IR (KBr): 3284 (NH) I 41, 16 1\,
1669 (C=O); IH NMR (CDCb): I 3 (t, I-L
-CH3), 3.8 (s, 3H, -OCH3), 4.3 (q, 2 , CH2),
(d, IH, ArH, J=8.4 Hz), 7.8 (m, 2H, rH),8.2
3H, ArH), 9.1 (bs, 1H, NH).
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yrimido[4,5-a}anthraquinone 3,4a-d. A mixture
f 2a or b (0.001 mole) and excess hydrazine
ydrate 0 the aliphatic amine (four folds), was
eated n er reflux in an oil-bath for 10 hr. The
solvent as removed, cooled and poured into
crush-ice. Hydrochloric acid was added dropwise
until t e precipitation was complete, filtered,
washed ith cold water and crystallised from
N.N-di ethylformamide:ethanol (90: 10), The physi-
cal dat afle recorded in Table L
3: I ( Br): 3428, 3324, 3238 (OH, NH), 1695,




Cr'R = C H2CH20H
d,R=CH2C6HS
IH NMR (DMSO-d6): 85.7 (s, 2H, NH2), 7,9-8,0
(m, 3H, ArH), 8.3-8.5 (m, 3H, ArH), 11.88 (s, IH,
OH orNH).
4a: IH NMR (DMSO-d6): 83,7 (s, 3H, CH3),
7,8-7,9 (m, 3H, ArH), 8.1-8.3 (m, 3H, ArH), 11.22
(s, IH, OH orNH).
4b: IH NMR (DMSO-d6): 8 1.35 (t, 3H, CH3),
4,28 (q, 2H, CH2), 7.8-8.3 (m, 6H, ArH), 11.15 (s,
IH, OH or NH).
4c: IH NMR (DMSO-d6): 83.60 (t, 2H, CH20),
3.90 (t, 2H, NCH2), 4.90 (br, IH, OH), 7.8-8.3 (rn,
6H, ArH), 11.21 (s, IH, OH or NH).
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Table I-The physical data of compounds 2-6
Compd R mp Yield Mol.
°c (%) fonnula N
2a OC2HS 161 86 C2oH17N06 65/.45 4.72 .
(65.39 4.66
2b OCH3 167 75 C'9H,sN06 64.72 4.31
(64.59 4.28
3 281 62 C'6H9N304 6lUO 3.05
(6il.54 2.95
4a CH3 >330 32 C17HION204 ~.52 3.32
(66.67 3.29
4b GfI2CH3 >330 35 C,sH12N204 67.33 3.80
«P.50 3.78
4c q-l2CH20H >330 40 CuH12N2OS 64.18 3.71
(~4.29 3:60
4d CH2C6Hs 298 55 C23H'4N204 72.08 3.63
(72.25 3.69
5 240 80 C,sH"N303 64.12 3.96
(64.05 3.94
6 248 90 C'6H9N303 65.90 3.04
65.98 3.11
4d: IH NMR (DMSO-d6): s 4.60 (s, 2H, CH2),
7.1 (s, 5H, ArH), 7.6-8.3 (m, 6H, ArH), 11.11 (s,
1H, OH or NH).
l-Aminoanthraquinone-2-carbohydrazide 5.
To compound 1 (2.95 g, 0.01 mole) in dry ethanol
(100 mL) was added excess hydrazine hydrate
(98%, 10 mL). The mixture was refluxed in a
boiling water-bath for 48 hr, at the end of which
the contents were concentrated. The reaction was
cooled and to it was gradually added 150-200 ml,
cold water accompanied by vigorous stirring,
precipitate was filtered, washed with water
followed by chilled methanol, dried and
crystallised from N,N-dimethylacetoamide. mp
240°, yield 2.25 g; IR: 3433, 3393, 3324 (NH),
1660 (C=O), IH NMR (DMSO-d6): s 4.6 (bs, 2H,
NH2), 7.4-8.3 (m, 6H, ArH), 8.8 (bs, 2H, NH2), 9.9
(bs, IH, NH); MS: M+ at mJz 281, and 250, 223,
193, 164.
3-Amin0-4(3H)..oxopyrimido[ 4,5-aJanthraqui-
none 6. A mixture of 5 (0.562 g, 0.002 molej-and
ethyl orthoformate (2 mL) was heated under reflux
for 10 hr. The solvent was then removed in
vacuum, and the residue was dispersed in ethanol.
The solid material obtained was filtered and
crystallised from N,N-dimethylformamide:ethanol
(80:20). IR (KBr): 3405, 3288 (NH), 1690, 1667
(C=O), 1625 (C=N), 1592, 1567 (C=C); IH NMR
(DMSO-d6): s 5.5 (s, 2H, NH2), 7.9 ( ,3H, Ar 1 ,
8.2 (m, 3H, ArH), 8.6 (s, 1H, N=CH).
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